
|Articles|October 6, 2003
Extended-cycle OC offers more convenience
Clinicians can soon offer women the convenience of an extended-cycle oral contraceptive (OC). The FDA recently approved levonorgestrel/ethinyl estradiol (Seasonale, Barr Laboratories) 0.15 mg/0.03 mg tablets for the prevention of pregnancy. The manufacturer plans a November 1 launch for Seasonale, the first extended-cycle OC to receive FDA approval.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Meeting at the Crossroads: The Role and Impact of PBMs and BOPs on Pharmacists
2
Pharmacies Adapting to IRA-Negotiated Drug Prices Despite Looming Financial Concerns
3
More Than 200 Organizations Denounce Childhood Vaccine Schedule Change
4
Adjunctive Lumateperone Maintains Remission Rates for Major Depressive Disorder
5









































































































































































































